Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
25.75
-1.33 (-4.91%)
At close: Jul 13, 2026, 4:00 PM EDT
25.92
+0.17 (0.67%)
After-hours: Jul 13, 2026, 7:33 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $4.98 billion as of July 13, 2026. Its market cap has decreased by -19.27% in one year.
Market Cap
4.98B
Enterprise Value
4.54B
1-Year Change
-19.27%
Ranking
Category
Stock Price
$25.75
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from $4.79B to $4.98B, an increase of 4.08%. That is a compound annual growth rate of 0.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 4.98B | 24.06% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 5.87B |
| Erasca | 5.76B |
| Dianthus Therapeutics | 5.34B |
| Travere Therapeutics | 5.26B |
| CRISPR Therapeutics AG | 5.25B |
| Celcuity | 5.25B |
| Oruka Therapeutics | 5.23B |
| Veradermics | 5.00B |